Long-Chain Fatty Acid Oxidation Disorders Online Disease Monitoring Program

Clinical trial NCT04812106 · TERMINATED

Trial details

NCT number: NCT04812106
Sponsor: Ultragenyx Pharmaceutical Inc
Status: TERMINATED
Study type: OBSERVATIONAL

Long-chain Fatty Acid Oxidation Disorders (LC-FAOD)

Start date: 2022-07-25
Primary completion: 2022-10-27
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.